MPO and colitis: 5-ASA, which was used as a reference drug, administered at the dose of 5 mg/kg i.c. (twice daily) significantly attenuated colitis as shown by decreased macroscopic score, reduced colon wall thickness, and MPO activity (Fig. 1a–c).